Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

<< Previous

Bullboard Posts

Next >>

Post by RazeKreationson Mar 21, 2022 1:34pm

162 Views

Post# 34531899

Microbix, Copan Group collaboration

Microbix, Copan Group and international KOL’s (Key Opinion Leaders) have been collaborating to advance the self-collection protocol for hrHPV (High-risk human papillomavirus) screening – to enhance convenience while maintaining accuracy.
As a result, Copan’s MSwab and a prospective prototype for a future Microbix REDxTMFLOQ control have been validated with most of the commercial HPV assays.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing